Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Tyr-gly-gly-phe-leu-arg;75106-70-6;6-Arg-leu-enkephalin;Dynorphin A (1-6);82008-60-4;LEU-ENKEPHALIN-ARG;(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;V1PIQ8ZW62;CHEMBL63188;D-Arginine,N2-[N-[N-[N-(N-L-tyrosylglycyl)glycyl]-L-phenylalanyl]-L-leucyl]- (9CI);enkephalin-Leu, Arg(6)-;Leu-enkephalin, arg(6)-;Leucine-enkephalin, arg(6)-;Enkephalin-leu, arginine(6)-;DYNORPHIN A 1-6;UNII-V1PIQ8ZW62;Tyr-Gly-Gly-Phe-Leu-Arg-OH;DTXSID90996605;BDBM50128084;L-Arginine, N(2)-(N-(N-(N-(N-L-tyrosylglycyl)glycyl)-L-phenylalanyl)-L-leucyl)-;FD108733;H-Tyr-Gly-Gly-Phe-Leu-Arg-OH; H-YGGFLR-OH;alpha-Neoendorphin (pig), 7-de-L-lysine-8-de-L-tyrosine-9-de-L-proline-10-de-L-lysine-;alpha-Neoendorphin, 7-de-L-lysine-8-de-L-tyrosine-9-de-L-proline-10-de-L-lysine-;N~2~-[14-Amino-5-benzyl-1,4,7,10,13-pentahydroxy-15-(4-hydroxyphenyl)-2-(2-methylpropyl)-3,6,9,12-tetraazapentadeca-3,6,9,12-tetraen-1-ylidene]arginine; |
M.F/Formula | C34H49N9O8 |
M.W/Mr. | 711.8 |
Sequence | One Letter Code:YGGFLR Three Letter Code:H-Tyr-Gly-Gly-Phe-Leu-Arg-OH |
InChI | InChI=1S/C34H49N9O8/c1-20(2)15-26(31(48)42-25(33(50)51)9-6-14-38-34(36)37)43-32(49)27(17-21-7-4-3-5-8-21)41-29(46)19-39-28(45)18-40-30(47)24(35)16-22-10-12-23(44)13-11-22/h3-5,7-8,10-13,20,24-27,44H,6,9,14-19,35H2,1-2H3,(H,39,45)(H,40,47)(H,41,46)(H,42,48)(H,43,49)(H,50,51)(H4,36,37,38)/t24-,25-,26-,27-/m0/s1 |
InChI Key | ILBHHEXPXBRSKB-FWEHEUNISA-N |
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.